LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.63 | 27.76 | 1578 | 4818 | 0.3275 | 0.7213 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.63 | 27.76 | 130 | 4818 | 0.0270 | 0.2307 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.63 | 27.76 | 1592 | 4818 | 0.3304 | 0.7234 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.63 | 27.76 | 2034 | 4818 | 0.4222 | 0.7811 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.63 | 27.76 | 2046 | 4818 | 0.4247 | 0.7825 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.33 | 27.76 | 1524 | 5117 | 0.2978 | 0.7027 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.33 | 27.76 | 1581 | 5117 | 0.3090 | 0.7110 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.33 | 27.76 | 168 | 5117 | 0.0328 | 0.2703 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.33 | 27.76 | 1702 | 5117 | 0.3326 | 0.7279 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.33 | 27.76 | 2166 | 5117 | 0.4233 | 0.7841 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.33 | 27.76 | 2176 | 5117 | 0.4252 | 0.7852 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.04 | 27.76 | 1729 | 5365 | 0.3222 | 0.7229 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.04 | 27.76 | 1792 | 5365 | 0.3340 | 0.7311 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.04 | 27.76 | 196 | 5365 | 0.0365 | 0.2935 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.04 | 27.76 | 1803 | 5365 | 0.3360 | 0.7325 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.04 | 27.76 | 2198 | 5365 | 0.4096 | 0.7783 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.04 | 27.76 | 2209 | 5365 | 0.4117 | 0.7794 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.74 | 27.76 | 1823 | 5606 | 0.3252 | 0.7271 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.74 | 27.76 | 1867 | 5606 | 0.3330 | 0.7325 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.74 | 27.76 | 229 | 5606 | 0.0408 | 0.3173 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.74 | 27.76 | 1836 | 5606 | 0.3275 | 0.7287 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.74 | 27.76 | 2365 | 5606 | 0.4218 | 0.7868 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.74 | 27.76 | 2382 | 5606 | 0.4249 | 0.7885 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.45 | 27.76 | 1935 | 5745 | 0.3368 | 0.7362 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.45 | 27.76 | 1987 | 5745 | 0.3458 | 0.7422 | MN20160318_Q01 | D18 |